CK-18, also known as cytokeratin 18, is an important protein found in epithelial tissues. This biomarker plays a crucial role in the identification and characterization of epithelial cells, making it a valuable tool in both clinical and research settings. CK-18 is particularly significant in the field of oncology, where it aids in the diagnosis and monitoring of certain cancers.
Understanding CK-18 can help healthcare professionals and researchers in various ways:
- **Cancer Diagnostics**: CK-18 levels can indicate the presence of certain types of tumors, providing essential information for treatment planning.
- **Pathological Studies**: It is widely used in pathology to differentiate between various types of tumors and assess their progression.
- **Monitoring Disease Progression**: Changes in CK-18 levels can help track the effectiveness of treatment and the progression of diseases.
- **Research Applications**: In research, CK-18 is utilized to study cell biology, cancer mechanisms, and the effects of therapies on epithelial cells.
CK-18 is trusted by thousands of healthcare professionals and researchers due to its proven quality and reliability in diagnostics. Regular updates and advancements in the understanding o-18 continue to enhance its applications in medical science. By integrating CK-18 into diagnostic processes, healthcare providers can offer better patient outcomes and personalized care.